Infection with Helicobacter pylori is one of the top risk factors for stomach cancer — but only a small proportion of individuals who carry the bacterium go on to develop cancer. Identifying who is ...

H pylori infection should be confirmed before eradication therapy. Accurate, cost-effective tests to diagnose the infection are now commercially available. Tests that do not require endoscopy include ...

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach and small bowel. It is often symptomless, but it can increase the risk of ulcers, gastritis, and cancer, all of which can ...

Background and Aim: A characteristic of gastric mucosa infected with Helicobacter pylori is infiltration of inflammatory cells, mainly consisting of neutrophils. The present study aimed to detect ...

A bacterium that infects roughly half the world’s population, often without producing symptoms for decades, may be responsible for the vast majority of stomach cancer cases projected to occur in the ...

BreathID Hp, a new non-invasive urea breath test for diagnosing H. pylori, has been made available by Exalenz Bioscience. The test takes approximately 10–15 minutes to complete and deliver results, ...

A peptic ulcer (white) is formed when stomach acid and bacteria irritate the lining of the stomach. Effective treatment may ease the pain of peptic ulcer disease and gastritis, prevent progression of ...

Objective: To assess adherence with guidelines for testing and treatment of infection and upper gastrointestinal symptoms. Study Design: Retrospective longitudinal cohort analysis of patient-level ...

Building on the BreathID Hp urea breath testing technology for Helicobacter pylori (H. pylori) detection, the new BreathID Hp Lab system provides cost-effective automated batch test analysis for ...

The FDA has expanded indications for a breath test that detects Helicobacter pylori, a bacterium responsible for gastritis and ulcers, making it the first of it’s kind approved for use in children ...

TEL AVIV, July 15 (Reuters) - Exalenz Bioscience, a developer of diagnostic systems that use a patient's breath to detect gastrointestinal and liver conditions, launched BreathID Hp, a next generation ...

CINCINNATI, July 25, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States ...